Dr. Ronald W. Cassada JR.
Internal Medicine (Internal Medicine Physician)
Prisma Health Medical Group Internal Medicine Center, 1801 Sunset Drive
Columbia, SC 29203
- Medicare participating
At a glance
- Medical school
- University of South Carolina School of Medicine (2021)
- Years since graduation
- 5
- In the NPI registry since
- 2021
- Medicare patients seen, 2024
- 124
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2021Medical school: University of South Carolina School of Medicine
- 2021Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
SC license RWC21A - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Musc Medical Center Charleston, SC
- Musc Health Columbia Medical Center Downtown Columbia, SC
Medical groups
- Apogee Medical Group South Carolina (74 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 124
- Services billed
- 349
- Patients’ average age
- 75
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Columbia, SC | 43 |
| Carvedilol Other prescribers in Columbia, SC | 20 |
| Lisinopril Other prescribers in Columbia, SC | 18 |
| Amlodipine Besylate Other prescribers in Columbia, SC | 16 |
| Trulicity (dulaglutide) Other prescribers in Columbia, SC | 16 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Columbia, SC | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $14.30 in total to this clinician.
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.30 |
|---|
| Food and Beverage | $14.30 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 5 companies. The companies reported $100,025 in research payments for these studies, mostly to the institutions running them.
- Post marketing commitment study to assess clinical efficacy & safety of current JN.1-based formulation with focus on lower-risk adults (50-64 years) to inform benefit-risk profile (PMC2)
ModernaTX, Inc. - Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
Sanofi US Services Inc. · Active, not recruiting · NCT05492578 - Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmon…
AstraZeneca Pharmaceuticals LP - A phase 3, 24-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC. - NB (Contrave) Cardiovascular Outcomes Trial
Currax Pharmaceuticals LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.